Yawei Liu

11PUBLICATIONS
15CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Central nervous systemMolecular targetsGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 23, 2025
Targeted degradation of endogenous YAP by nanobody bioPROTAC inhibits tumor progression.

Runhua Zhou, Huifang Wang, Gui-Ming Zhang

|Aug 21, 2023
Nucleo-cytoplasmic shuttling of 14-3-3 epsilon carrying hnRNP C promotes autophagy.

Manlan Guo, Minyi He, Yi Zhang

|Oct 19, 2022
Status Quo and Research Trends of Neurosurgical Departments in China: Bibliometric and Scientometric Analyses.

Bowen Ni, Minyi He, Bei Cao

|Feb 21, 2022
Recycling of SLC38A1 to the plasma membrane by DSCR3 promotes acquired temozolomide resistance in glioblastoma.

Rui Lin, Yimin Xu, Sidi Xie

|May 27, 2021
Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.

Yaomin Li, Xiran Wang, Songtao Qi

|Dec 14, 2019
Quantitative Proteomics Analysis Reveals Nuclear Perturbation in Human Glioma U87 Cells treated with Temozolomide.

Jinglin Guo, Guo-Zhong Yi, Zhifeng Liu

Pageof 2

Frequent Collaborators

2 joint publications

Songtao Qi

1 joint publications

Xue-Gang Sun

1 joint publications

Jing Tang

1 joint publications

Bowen Ni